# Serum Albumin/Globulin Ratio and Cognitive Function in Americans: A Linear Association

**Authors:** Ling Tong, Qin Ye, Jia Zhu, Yuan Wang, Gang Chen, Qinyan Wang

PMC · DOI: 10.1002/brb3.71015 · Brain and Behavior · 2025-10-29

## TL;DR

This study finds that a lower serum albumin/globulin ratio is linked to a higher risk of cognitive impairment in Americans.

## Contribution

The study identifies the AGR as a potential new biomarker for cognitive decline.

## Key findings

- Lower AGR values are associated with increased cognitive impairment risk (OR: 0.550).
- Each unit increase in AGR reduces cognitive impairment prevalence by 45% in the fourth quartile.
- The AGR-cognitive impairment relationship is linear and not influenced by gender or education.

## Abstract

Nutritional status and chronic inflammation play crucial roles in cognitive impairment. The albumin–globulin ratio (AGR) serves as a biomarker for assessing nutrition and inflammation; however, its relationship with cognitive function remains unclear. The objective of this study is to investigate the correlation between them.

The present study utilized data obtained from the National Health and Nutrition Examination Surveys conducted during the years 2001–2002 and 2011–2014. The relationships between the AGR and cognitive impairment were assessed through the application of weighted logistic regression analysis, smoothed fitted curves, the investigation of threshold effects, and the execution of subgroup analysis. In this study, participants with lower AGR values had a greater incidence of cognitive impairment.

The results of the logistical regression model, following adjustments for all potential influencing factors, demonstrated that the AGR may be associated with an increased incidence of cognitive impairment (OR: 0.550, 95% CI: 0.359, 0.843). This finding indicates that for each unit increase in the AGR within the fourth quartile, the prevalence of cognitive impairment decreased by 45%. Smoothed fitted curves and threshold effects demonstrated a linear relationship between the AGR and cognitive impairment (OR: 0.448, 95% CI: 0.312, 0.642). Subgroup analysis revealed that the association between the AGR and cognitive impairment was not influenced by factors such as gender, education, or hyperlipidemia.

Having a lower AGR may be linked to a higher risk of cognitive impairment.

The serum albumin/globulin ratio (AGR) can serve as a new biomarker for identifying individuals at risk of cognitive decline. AGR is an inexpensive inflammatory marker that is easily obtainable in clinical practice.

## Full-text entities

- **Genes:** ALB (albumin) [NCBI Gene 213] {aka FDAHT, HSA, PRO0883, PRO0903, PRO1341}
- **Diseases:** hyperlipidemia (MESH:D006949), chronic inflammation (MESH:D007249), cognitive impairment (MESH:D003072)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12571972/full.md

## Figures

3 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12571972/full.md

## References

50 references — full list in the complete paper: https://tomesphere.com/paper/PMC12571972/full.md

---
Source: https://tomesphere.com/paper/PMC12571972